Navigation Links
VetCentric Releases Findings of Pet Owner Survey
Date:5/7/2009

Data Results in New Compounded Medication Program

GLEN BURNIE, Md., May 7 /PRNewswire/ -- VetCentric, Inc., the nation's largest practice-to-home delivery veterinary pharmacy today announced the results of its recent online survey of more than 1,200 pet owners from across the U.S.

Key findings indicate that pet owners feel very strongly about having convenient services and options that help them improve compliance. It also indicated a very strong preference for ordering medications directly through their veterinary clinics to maintain veterinarian involvement. Specifically:

  • 96% of pet owners stated that it was important to be able to order their pet's medication through their veterinarian to ensure that the vet remained involved with the pet's care (51% stated that this is "very important")
  • 90% of pet owners stated it was important to have the convenience of home delivery for their pet's medications
  • 87% of pet owners stated it was important to have automatic refills of the pet's medications so they didn't have to worry about missing a dose
  • 87% of pet owners stated it was important to have a variety of medication forms and flavorings that make it easier for pets to take their medications

To meet the needs pet owners identified in this research and support its partner practices, VetCentric recently launched a new compounded medications program that provides free home delivery while encouraging treatment regime compliance. The program includes free 2nd day shipping for first fills and free standard shipping for all refills when the prescription is set up to automatically refill. Complete information about the program is available through the recently launched compounding microsite at www.vetcentric.com/compounding.

"The results of this survey strongly support VetCentric's core belief that veterinarian involvement is crucial to maintaining healthy pets. It's very exciting to see that pet owners feel strongly about both the convenience of home delivery and keeping their veterinarian involved in their pet's care. This data was instrumental in the development of our new compounded medications program," said Ted Root, President and CEO of VetCentric.

More than 1,200 pet owners completed the survey and all of them are clients of clinics that presently have a VetCentric account. Approximately 50% of respondents have placed at least one order through VetCentric.

About VetCentric:

VetCentric, Inc., a privately-held company headquartered in the Baltimore-Washington area, is the only national veterinary-focused pharmacy offering home delivery of FDA and EPA approved pharmaceuticals, compounded medications and diets to pet owners on behalf of veterinary clinics. Its comprehensive suite of services provides clinics with an online store that allows customized product selection and pricing, home delivery and client communications. VetCentric firmly supports the Veterinarian-Client-Patient relationship in all its business practices, allowing veterinarians to stay at the center of their patients' care while improving service, encouraging compliance and decreasing costs.

In the past 10 years, VetCentric has partnered with more than 9,000 veterinary clinics to fill in excess of 2 million orders for nearly 500,000 pet owners. Its pharmacy complies with the licensing and inspection requirements of all states in which it does business. For more information, please visit www.vetcentric.com.


'/>"/>
SOURCE VetCentric, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. VetCentric Partners with Dechra Veterinary Products
2. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
5. Verdict One Releases Directory of Board Certified Attorneys for Consumers
6. Academy releases emergency preparedness tools to enable millions more people to shelter in place
7. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
8. MITEM Releases Blue Iris eLaborate 8.6
9. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
10. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
11. URAC Releases Issue Briefs Examining Stakeholders Views of Care Coordination Along the Healthcare Continuum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Raton (PRWEB) , ... September 19, 2017 , ... ... the El Naturalista brand, developed by ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. ... in Spain, and El Naturalista is a trusted, well-respected brand reliant on the ...
(Date:9/19/2017)... ... ... For decades doctors, nurses, and other healthcare providers have been trained to ... calculating their cardiovascular disease (CVD) risk in the next 10 years. , Imagine ... an estimated 10-year risk prediction! , Imagine if the weatherman says there is a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... with the Davidson Fellows Scholarship on September 27 at a reception in Washington ... Technology, Engineering, Mathematics, Literature and Music. , “I am honored to be a ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency nursing expertise, skill ... Emergency Nurse (CEN®) certification according to a large-scale study announced today by ... conducted by the Human Resources Research Organization (HumRRO) in late 2016 and early ...
(Date:9/18/2017)... Bangkok, Thailand (PRWEB) , ... September 19, 2017 ... ... in Asia Pacific’s protein ingredient market , expected to grow at the ... Frost & Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology: